Collegium Pharmaceutical, Inc.

NasdaqGS COLL

Collegium Pharmaceutical, Inc. EBITDA for the Trailing 12 Months (TTM) ending September 30, 2024: USD 346.72 M

Collegium Pharmaceutical, Inc. EBITDA is USD 346.72 M for the Trailing 12 Months (TTM) ending September 30, 2024, a 34.59% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.

Collegium Pharmaceutical, Inc. EBITDA for the Trailing 12 Months (TTM) ending September 30, 2023 was USD 257.62 M, a 155.43% change year over year.
Collegium Pharmaceutical, Inc. EBITDA for the Trailing 12 Months (TTM) ending September 30, 2022 was USD 100.86 M, a -25.60% change year over year.
Collegium Pharmaceutical, Inc. EBITDA for the Trailing 12 Months (TTM) ending September 30, 2021 was USD 135.55 M, a 54.50% change year over year.
Collegium Pharmaceutical, Inc. EBITDA for the Trailing 12 Months (TTM) ending September 30, 2020 was USD 87.74 M, a 359.31% change year over year.

Key data

Date	EBITDA	Net Income	EPS (Diluted)	Shares (Diluted, Weighted)

NasdaqGS: COLL

Collegium Pharmaceutical, Inc.

CEO	Mr. Vikram Karnani
IPO Date	May 7, 2015
Location	United States
Headquarters	100 Technology Center Drive
Employees	197
Sector	Health Care
Industries Pharmaceuticals

Description

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.

Key trends

Past 5 years